Assesses Hunter syndrome (MPS II) disease activity through uGAG levels, neurocognitive function, 6-minute walk test, joint range of motion, and cardiac valve status for enzyme replacement therapy monitoring.
Enter the values for the scenario you are assessing. Assesses Hunter syndrome (MPS II) disease activity through uGAG levels, neurocognitive function, 6-minute walk test, joint range of motion, and cardiac valve status for enzyme replacement therapy monitoring. Use the mps ii assessment result to inform your calculation.